Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr
Pharmacy Times
JULY 2, 2025
They can collect documentation on prior preventive therapies, baseline MMDs, and follow-up outcomes to support prior authorization, including site-of-care arrangements. of participants discontinued due to adverse effects.
Let's personalize your content